瑞普利蒙生物 REPL
$21.62 +$1.60 (+7.99%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $21.61 -0.05%
开盘$20.20
昨收$20.02
当日区间$20.20 – $21.91
成交量2.98M
市值$2.05B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Sep 2026
营收$0.00
营业利润-$56.04M+33.2% YoY
净利润-$57.12M+31.3% YoY
摊薄每股收益-$0.54+40.0% YoY
自由现金流-$47.78M+42.1% YoY
经营现金流-$47.70M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-115.8%
资产收益率-71.0%
投入资本回报率-77.4%
流动比率7.11
负债/资产比率45.2%
现金及投资$307.83M
总负债$123.15M
净现金（净负债）$184.68M
利润表
| 项目 | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $56.04M | $67.95M | $318.32M | $72.87M | $71.53M |
| 销售及管理费用 | $21.92M | $18.97M | $98.74M | $21.01M | $18.73M |
| 研发费用 | $34.37M | $49.28M | $221.18M | $52.32M | $53.14M |
| 其他营业费用 | -$238,000.00 | -$296,000.00 | -$1.60M | -$466,000.00 | -$341,000.00 |
| 营业利润 | -$56.04M | -$67.95M | -$318.32M | -$72.87M | -$71.53M |
| 非经营性利息净收入（支出） | -$3.03M | -$3.09M | -$8.86M | -$2.88M | -$1.98M |
| 非经营性利息支出 | $3.03M | $3.09M | $8.86M | $2.88M | $1.98M |
| 其他收入（支出） | $1.95M | $1.27M | $12.68M | $2.29M | $2.27M |
| 证券出售收益 | $1.88M | $1.96M | $13.63M | $2.37M | $2.85M |
| 其他非经营性收入（支出） | $67,000.00 | -$688,000.00 | -$942,000.00 | -$77,000.00 | -$580,000.00 |
| 税前利润 | -$57.12M | -$69.77M | -$314.49M | -$73.46M | -$71.24M |
| 净利润 | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| 持续经营利润 | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| 归属母公司净利润 | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| 归属普通股股东净利润 | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| 基本每股收益 | -$0.54 | -$0.72 | -$3.38 | -$0.76 | -$0.77 |
| 摊薄每股收益 | -$0.54 | -$0.72 | -$3.38 | -$0.76 | -$0.77 |
| 税费 | – | – | -$551,000.00 | -$240,000.00 | -$311,000.00 |
资产负债表
| 项目 | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| 总资产 | $373.94M | $252.45M | $332.39M | $332.39M | $333.59M |
| 流动资产合计 | $324.04M | $200.81M | $279.12M | $279.12M | $280.35M |
| 现金及现金等价物与短期投资 | $307.83M | $195.33M | $268.89M | $268.89M | $269.14M |
| -现金及现金等价物 | $307.83M | $185.36M | $209.02M | $209.02M | $122.95M |
| -短期投资 | $0.00 | $9.97M | $59.87M | $59.87M | $146.19M |
| 应收款 | $0.00 | $0.00 | $1.62M | $1.62M | $2.96M |
| 存货 | $9.87M | – | – | – | – |
| 其他流动资产 | $6.34M | $5.48M | $8.61M | $8.61M | $8.26M |
| 非流动资产合计 | $49.91M | $51.64M | $53.27M | $53.27M | $53.24M |
| 固定资产净值 | $44.73M | $46.70M | $48.62M | $48.62M | $50.33M |
| -固定资产原值 | $63.17M | $64.37M | $65.36M | $65.36M | $66.29M |
| -累计折旧 | -$18.44M | -$17.67M | -$16.73M | -$16.73M | -$15.96M |
| 其他非流动资产 | $5.18M | $4.94M | $4.65M | $4.65M | $2.90M |
| 负债合计 | $169.16M | $146.80M | $166.23M | $166.23M | $123.05M |
| 流动负债合计 | $45.55M | $38.41M | $58.23M | $58.23M | $50.09M |
| 应付款 | $5.96M | $4.26M | $6.67M | $6.67M | $5.65M |
| -应付账款 | $5.96M | $4.26M | $6.67M | $6.67M | $5.65M |
| 一年内应计费用 | $22.90M | $22.95M | $27.28M | $27.28M | $24.68M |
| 短期债务及融资租赁负债 | $4.04M | $4.04M | $4.04M | $4.04M | $4.08M |
| -一年内到期融资租赁负债 | $4.04M | $4.04M | $4.04M | $4.04M | $4.08M |
| 其他流动负债 | $3.91M | $2.04M | $2.76M | $2.76M | $1.24M |
| 非流动负债合计 | $123.61M | $108.39M | $108.00M | $108.00M | $72.96M |
| 长期债务及融资租赁负债 | $123.15M | $107.94M | $107.55M | $107.55M | $72.27M |
| -长期债务 | $99.77M | $84.11M | $83.31M | $83.31M | $47.63M |
| -长期融资租赁负债 | $23.39M | $23.82M | $24.24M | $24.24M | $24.64M |
| 其他非流动负债 | $455,000.00 | $455,000.00 | $455,000.00 | $455,000.00 | $693,000.00 |
| 股东权益合计 | $204.78M | $105.65M | $166.16M | $166.16M | $210.54M |
| 股东权益 | $204.78M | $105.65M | $166.16M | $166.16M | $210.54M |
| 股本 | $95,000.00 | $84,000.00 | $82,000.00 | $82,000.00 | $79,000.00 |
| -普通股 | $95,000.00 | $84,000.00 | $82,000.00 | $82,000.00 | $79,000.00 |
| 资本公积 | $1.59B | $1.43B | $1.42B | $1.42B | $1.39B |
| 留存收益 | -$1.39B | -$1.33B | -$1.26B | -$1.26B | -$1.19B |
| 不影响留存收益的损益 | $5.92M | $5.98M | $5.40M | $5.40M | $5.56M |
| -其他应收款 | – | – | $1.62M | $1.62M | $2.96M |
现金流量表
| 项目 | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$47.70M | -$75.73M | -$280.34M | -$56.16M | -$65.96M |
| 持续经营经营活动现金流净额 | -$47.70M | -$75.73M | -$280.34M | -$56.16M | -$65.96M |
| 持续经营净利润 | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| 持续经营损益 | $67,000.00 | -$688,000.00 | -$942,000.00 | -$77,000.00 | -$581,000.00 |
| 折旧、折耗与摊销 | $773,000.00 | $937,000.00 | $3.33M | $769,000.00 | $848,000.00 |
| 其他非现金项目 | $1.47M | $1.62M | $5.13M | $1.49M | $1.23M |
| 营运资金变动 | -$4.18M | -$15.50M | -$3.84M | $6.88M | -$3.43M |
| -应收款变动 | -$233,000.00 | $1.35M | $451,000.00 | -$464,000.00 | -$349,000.00 |
| -预付资产变动 | -$851,000.00 | $3.13M | -$232,000.00 | -$362,000.00 | $36,000.00 |
| -应付账款及应计费用变动 | $7.00M | -$19.76M | -$2.76M | $7.82M | -$2.64M |
| -其他流动负债变动 | -$226,000.00 | -$218,000.00 | -$1.31M | -$116,000.00 | -$475,000.00 |
| 投资活动现金流净额 | $9.76M | $49.99M | $310.84M | $86.51M | $75.12M |
| 持续经营投资活动现金流净额 | $9.76M | $49.99M | $310.84M | $86.51M | $75.12M |
| 固定资产购置及出售净额 | $3,000.00 | -$6,000.00 | -$4.22M | -$5,000.00 | -$135,000.00 |
| 投资购置及出售净额 | $9.76M | $50.00M | $315.07M | $86.51M | $75.26M |
| 筹资活动现金流 | $160.55M | $800,000.00 | $66.29M | $55.68M | $10.45M |
| 持续经营筹资活动现金流净额 | $160.55M | $800,000.00 | $66.29M | $55.68M | $10.45M |
| 债务发行及偿还净额 | $14.79M | -$203,000.00 | $34.26M | $34.80M | -$195,000.00 |
| 股票期权行使所得 | $35.78M | $1.00M | $883,000.00 | $92,000.00 | $282,000.00 |
| 期末现金余额 | $309.54M | $187.06M | $210.73M | $210.73M | $124.66M |
| 现金净变动 | $122.61M | -$24.94M | $96.79M | $86.02M | $19.62M |
| 期初现金余额 | $187.06M | $210.73M | $112.82M | $124.66M | $104.00M |
| 汇率变动影响 | -$136,000.00 | $1.27M | $1.11M | $50,000.00 | $1.04M |
| 自由现金流 | -$47.78M | -$75.73M | -$284.57M | -$56.17M | -$66.09M |
| -其他流动资产变动 | – | – | $0.00 | $0.00 | $0.00 |
| 普通股发行净额 | – | – | $31.15M | $20.78M | $10.36M |
暂无评论——快来第一个聊聊 REPL。
登录后参与讨论。